In addition to working with a number of NGOs in Hong Kong and in the South East Asia region, the Peter Bennett Foundation has established major long-term partnerships with the following organizations:
THE BENNETT INSTITUTE FOR PUBLIC POLICY, UNIVERSITY OF CAMBRIDGE
The Bennett Institute for Public Policy at the University of Cambridge is committed to interdisciplinary academic and policy research into the major challenges facing the world, and to high-quality teaching of the knowledge and skills required in public service.
The goal of the Bennett Institute for Public Policy is to rethink public policy in an era of turbulence and inequality. Its research connects the world-leading work in technology and science at Cambridge with the economic and political dimensions of policymaking. It is committed to outstanding teaching, policy engagement, and to devising sustainable and long-lasting solutions.
The Bennett Institute for Public Policy aims to develop successful and sustainable solutions to some of the most pressing problems of our time and is currently working in the following core areas:
THE BENNETT INSTITUTE FOR APPLIED DATA SCIENCE, UNIVERSITY OF OXFORD
The Bennett Institute for Applied Data Science at the University of Oxford has the mission of pioneering the better use of data, evidence and digital tools in healthcare and policy.
In addition to taking huge datasets and turning them into traditional academic research papers, the Bennett Institute for Applied Data Science also builds live, interactive data-driven tools and services for everyone to use. By using modern, open methods and sharing all analysis and platform code online, it supports reproducibility, trust, and efficient re-use.
The work of the Bennett Institute for Applied Data Science is extremely high impact: the OpenPrescribing.net tool sees over 130,000 unique users a year; the TrialsTracker tools have received extensive global media coverage and help set the policy agenda; and the OpenSAFELY.org platform is operating across 40% of England’s full pseudonymised patient records to generate key insights for clinicians and policymakers during COVID-19.